サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1454140

パクリタキセル注射液市場：適応症タイプ別、用途別、国別、地域別 - 産業分析、市場規模、市場シェア、予測、2024-2032年

Paclitaxel Injection Market, By Indication Type, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日: | 発行: AnalystView Market Insights | ページ情報: 英文 311 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
パクリタキセル注射液市場：適応症タイプ別、用途別、国別、地域別 - 産業分析、市場規模、市場シェア、予測、2024-2032年
出版日: 2024年03月04日
発行: AnalystView Market Insights
ページ情報: 英文 311 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートハイライト

パクリタキセル注射液の市場規模は2023年に61億452万米ドルとなり、2024年から2032年にかけてCAGR 12.90%で拡大

パクリタキセル注射液市場力学

がん患者数の増加が市場成長を促進する見込み

がん患者数は増加の一途をたどっており、がんは世界の健康上の大きな問題となっています。人口の高齢化、ライフスタイルの変化、環境の影響、がん発見・診断の進歩など、さまざまな要因が世界のがん有病率の上昇に関与しています。米国国立保健統計センターによると、2023年には米国で新たに195万8310人のがん患者が発生し、60万9820人ががんに関連して死亡すると推定されています。また、特に新興経済諸国におけるヘルスケア・インフラの改善により、パクリタキセル注射液市場の拡大が見込まれています。とはいえ、規制における課題が市場の成長を阻害する可能性もあります。

パクリタキセル注射液市場-主要インサイト

弊社リサーチアナリストの分析によると、世界市場は予測期間（2024-2032年）に約12.90%のCAGRで毎年成長すると推定されます。

市場セグメンテーションによると、2023年には乳がんが最大の市場シェアを示すと予測されています。

用途別では、2023年に病院が主要なタイプでした。

地域別では、北米が2023年の売上高でトップ

パクリタキセル注射液市場-セグメンテーション分析：

パクリタキセル注射液の世界市場は、適応症タイプ、用途、地域に基づいてセグメント化されます。

市場は適応症タイプによって11のカテゴリーに区分される：前立腺がん、乳がん、非小細胞肺がん、エイズ関連カポジ肉腫、卵巣がん、胃がん、子宮頸がん、食道がん、精巣がん、肺がん、膵がん、その他です。乳がんが市場で最大のシェアを占めています。パクリタキセルは、乳がん治療に広く認知され、一般的に使用されている化学療法薬です。早期乳がんや転移性乳がんなど、さまざまなサブタイプの乳がんに対して、主要ながん治療ガイドラインで推奨されている標準治療レジメンの一部です。

市場は用途によって3つのセグメントに分類される：がん研究センター、病院、その他です。市場の成長を牽引しているのは、主に病院部門です。病院は、化学療法やその他のがん治療を患者に提供する上で極めて重要な役割を担っており、乳がんなどさまざまな種類のがんの標準治療としてパクリタキセルの投与が行われています。

パクリタキセル注射液市場-地理的洞察

地域的には、この市場は北米、ラテンアメリカ、欧州、アジア太平洋、中東・アフリカにまたがっています。これらの地域は、事業活動に貢献している国によってさらに区分されます。アジア太平洋地域は、標的療法に対する需要の増加により、市場の成長をリードすると予想されています。健康な組織への害を最小限に抑えながらがん細胞に焦点を当てる標的療法は、アジア太平洋地域で人気を集めています。パクリタキセルは、標的治療薬と併用されたり、精密医療アプローチで使用されたりすることで、これらの治療法の有効性を高め、市場拡大を後押ししています。中国だけでも30の適応症で20品目（25.6％）が承認され、そのうち14品目（70.0％）が2017年以降に承認されました。米国医師会の予測では、20品目中15品目（75.0％）が標的治療薬、20品目中4品目（20.0％）が免疫療法でした。今後、欧州は、ヘルスケアインフラへの投資と支出の増加により、次年度の市場成長において第2位の地域となる見込みです。

パクリタキセル注射液市場-競合情勢：

パクリタキセル注射液のサプライヤー間の競合は、規制、経済、技術、商業的要因の多面的な組み合わせの影響を受けています。刻々と変化するヘルスケア業界で競争力を確立するためには、メーカーはこれらの力学を戦略的に操る必要があります。パクリタキセル注射液市場における競合他社との差別化は、技術革新と研究開発投資によって推進されます。メーカーには、治療成績を高め、患者の利便性を向上させ、治療に関連する副作用を最小限に抑えることができる新しい製剤、送達技術、または併用療法を開発する機会があります。

目次

第1章 パクリタキセル注射液市場概要

  • 調査範囲
  • 市場推定年数

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 パクリタキセル注射液の主要な市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 今後の市場動向

第4章 パクリタキセル注射液業界の調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しのマッピング
  • 規制枠組みの分析

第5章 パクリタキセル注射液市場：COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19後の影響分析

第6章 パクリタキセル注射液市場情勢

  • パクリタキセル注射液市場シェア分析、2023年
  • 主要メーカー別の内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 パクリタキセル注射液市場-適応症タイプ別

  • 概要
    • 適応症タイプ別のセグメントシェア分析
    • 前立腺がん
    • 乳がん
    • 非小細胞肺がん
    • エイズ関連のカポジ肉腫
    • 卵巣がん
    • 胃がん
    • 子宮頸がん
    • 食道がん
    • 精巣がん
    • 肺がん
    • 膵臓がん
    • その他

第8章 パクリタキセル注射液市場-用途別

  • 概要
    • 用途別のセグメントシェア分析
    • がん研究センター
    • 病院
    • その他

第9章 パクリタキセル注射液市場-地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋地域の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東とアフリカ
    • 概要
    • 中東とアフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第10章 主要ベンダー分析-パクリタキセル注射液業界

  • 競合ダッシュボード
  • 企業プロファイル
    • Pfizer
    • Celgene Corporation
    • Fresenius Kabi Oncology Ltd
    • Abbott Laboratories
    • Onco Therapies Ltd（Strides Arcolab Ltd.）
    • Sagent Pharmaceuticals
    • Bristol Myers Squibb
    • Luye Pharma Group
    • NOVASEP
    • Others

第11章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data Indication Types
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Paclitaxel Injection Market: Indication Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Indication Type
  • TABLE Global Paclitaxel Injection Market, by Indication Type 2019-2032 (USD Million)
  • TABLE Paclitaxel Injection Market: Application Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Paclitaxel Injection Market, by Application 2019-2032 (USD Million)
  • TABLE Paclitaxel Injection Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Paclitaxel Injection Market, by Region 2019-2032 (USD Million)
  • TABLE North America Paclitaxel Injection Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Paclitaxel Injection Market, by Indication Type, 2019-2032 (USD Million)
  • TABLE North America Paclitaxel Injection Market, by Application, 2019-2032 (USD Million)
  • TABLE Europe Paclitaxel Injection Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Paclitaxel Injection Market, by Indication Type, 2019-2032 (USD Million)
  • TABLE Europe Paclitaxel Injection Market, by Application, 2019-2032 (USD Million)
  • TABLE Asia Pacific Paclitaxel Injection Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Paclitaxel Injection Market, by Indication Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Paclitaxel Injection Market, by Application, 2019-2032 (USD Million)
  • TABLE Latin America Paclitaxel Injection Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Paclitaxel Injection Market, by Indication Type, 2019-2032 (USD Million)
  • TABLE Latin America Paclitaxel Injection Market, by Application, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Paclitaxel Injection Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Paclitaxel Injection Market, by Indication Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Paclitaxel Injection Market, by Application, 2019-2032 (USD Million)

List of Figures

  • FIGURE Paclitaxel Injection Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2023
  • FIGURE Indication Type segment market share analysis, 2023 & 2032
  • FIGURE Indication Type segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Application segment market share analysis, 2023 & 2032
  • FIGURE Application segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Regional segment market share analysis, 2023 & 2032
  • FIGURE Regional segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE North America Paclitaxel Injection Market share and leading players, 2023
  • FIGURE Europe Paclitaxel Injection Market share and leading players, 2023
  • FIGURE Asia Pacific Paclitaxel Injection Market share and leading players, 2023
  • FIGURE Latin America Paclitaxel Injection Market share and leading players, 2023
  • FIGURE Middle East and Africa Paclitaxel Injection Market share and leading players, 2023
  • FIGURE North America market share analysis by country, 2023
  • FIGURE U.S. Paclitaxel Injection Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Canada Paclitaxel Injection Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Europe Paclitaxel Injection Market share analysis by country, 2023
  • FIGURE Germany Paclitaxel Injection Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Spain Paclitaxel Injection Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Italy Paclitaxel Injection Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE France Paclitaxel Injection Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE UK Paclitaxel Injection Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Russia Paclitaxel Injection Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Netherlands Paclitaxel Injection Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Sweden Paclitaxel Injection Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Poland Paclitaxel Injection Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of the Europe Paclitaxel Injection Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Asia Pacific Paclitaxel Injection Market share analysis by country, 2023
  • FIGURE India Paclitaxel Injection Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE China Paclitaxel Injection Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Japan Paclitaxel Injection Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE South Korea Paclitaxel Injection Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Australia Paclitaxel Injection Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Thailand Paclitaxel Injection Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Indonesia Paclitaxel Injection Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Phillipines Paclitaxel Injection Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of APAC Paclitaxel Injection Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Paclitaxel Injection Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Paclitaxel Injection Market share analysis by country, 2023
  • FIGURE Brazil Paclitaxel Injection Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Mexico Paclitaxel Injection Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Argentina Paclitaxel Injection Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Colombia Paclitaxel Injection Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of LATAM Paclitaxel Injection Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Paclitaxel Injection Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Paclitaxel Injection Market share analysis by country, 2023
  • FIGURE Saudi Arabia Paclitaxel Injection Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE United Arab Emirates Paclitaxel Injection Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Israel Paclitaxel Injection Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Turkey Paclitaxel Injection Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Algeria Paclitaxel Injection Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Egypt Paclitaxel Injection Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of MEA Paclitaxel Injection Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
目次
Product Code: ANV2321

REPORT HIGHLIGHT

Paclitaxel Injection Market size was valued at USD 6,104.52 Million in 2023, expanding at a CAGR of 12.90% from 2024 to 2032.

Paclitaxel is a chemotherapy medication designed to combat cancer by attacking fast-growing cancer cells. It is administered via injection and is typically prescribed for late-stage ovarian, breast, non-small cell lung cancer, and Kaposi sarcoma. Kaposi sarcoma, a type of cancer that impacts the skin and mucous membranes, is frequently diagnosed in individuals with AIDS. It is crucial that Paclitaxel (formulated with polyoxyethylated castor oil) injections are administered by a skilled oncologist in a hospital or medical setting.

Paclitaxel Injection Market- Market Dynamics

The rise in the number of cancer patients is expected to propel the market growth

Cancer poses a major worldwide health issue, as the number of cancer cases continues to increase. Various factors, including aging populations, lifestyle modifications, environmental influences, and advancements in cancer detection and diagnosis, all play a role in the rising prevalence of cancer globally. According to the National Center for Health Statistics, it is estimated that in 2023, there will be 1,958,310 new cases of cancer and 609,820 cancer-related deaths in the United States. Additionally, the growth of the paclitaxel injection market is expected to expand due to the improvement of healthcare infrastructure, especially in developing economies. Nevertheless, challenges in regulations may impede the market's growth.

Paclitaxel Injection Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 12.90% over the forecast period (2024-2032)

Based on Indication Type segmentation, Breast Cancer was predicted to show maximum market share in the year 2023

Based on application segmentation, Hospitals was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Paclitaxel Injection Market- Segmentation Analysis:

The Global Paclitaxel Injection Market is segmented on the basis of Indication Type, Application, and Region.

The market is segmented into eleven categories according to Indication Type: Prostate Cancer, Breast Cancer, Non-small Cell Lung Cancer, AIDS-related Kaposi's sarcoma, Ovarian Cancer, Stomach Cancer, Cervical Cancer, Esophageal Cancer, Testicular Cancer, Lung Cancer, Pancreatic Cancer, and Others. Breast Cancer holds the largest share in the market. Paclitaxel is a widely recognized and commonly used chemotherapy medication for treating breast cancer. It is part of the standard treatment regimens recommended by major cancer treatment guidelines for various subtypes of breast cancer, including early-stage and metastatic disease.

The market is categorized into three segments according to their application: Cancer Research Centers, Hospitals, and Others. The growth of the market is primarily driven by the hospital sector. Hospitals play a pivotal role in delivering chemotherapy and other cancer treatments to patients, which includes the administration of paclitaxel as a standard treatment for different types of cancer, such as breast cancer.

Paclitaxel Injection Market- Geographical Insights

Geographically, this market spans across North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further segmented by countries contributing to business activities. The Asia Pacific region is expected to lead the market growth, driven by the increasing demand for targeted therapies. Targeted therapies, which focus on cancer cells while minimizing harm to healthy tissues, are gaining popularity in the Asia Pacific region. Paclitaxel, when combined with targeted agents or used in precision medicine approaches, enhances the effectiveness of these therapies, thus boosting market expansion. In China alone, twenty drugs (25.6%) for 30 indications were approved, with 14 (70.0%) of them authorized after 2017; 15 out of 20 (75.0%) were targeted therapies, and 4 out of 20 (20.0%) were immunotherapies, as projected by the American Medical Association. Looking ahead, Europe is poised to become the second largest region for market growth in the upcoming year, thanks to increased investments in healthcare infrastructure and expenditures.

Paclitaxel Injection Market- Competitive Landscape:

The competition among suppliers of paclitaxel injection is influenced by a multifaceted combination of regulatory, economic, technological, and commercial factors. To establish a competitive edge in the ever-changing healthcare industry, manufacturers need to strategically navigate these dynamics. Competitive differentiation within the paclitaxel injection market is driven by innovation and investment in research and development. Manufacturers have the opportunity to develop new formulations, delivery technologies, or combination therapies that can enhance therapeutic outcomes, improve patient convenience, and minimize treatment-related side effects.

Recent Developments:

Pfizer has revealed the introduction of three new biosimilars, namely ZIRABEV (bevacizumab-bvzr), RUXIENCE (rituximab-pvvr), and TRAZIMERA (trastuzumab-qyyp) in the United States (U.S.). These medications are anticipated to be released at the most competitive Wholesale Acquisition Cost (WAC) compared to other bevacizumab, rituximab, or trastuzumab products currently in the market, offering a significantly reduced price compared to the original product.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PACLITAXEL INJECTION MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Pfizer

Celgene Corporation

Fresenius Kabi Oncology Ltd

Abbott Laboratories

Onco Therapies Ltd (Strides Arcolab Ltd.)

Sagent Pharmaceuticals

Bristol Myers Squibb

Luye Pharma Group

NOVASEP

Others

GLOBAL PACLITAXEL INJECTION MARKET, BY INDICATION TYPE- MARKET ANALYSIS, 2019 - 2032

  • Prostate Cancer
  • Breast Cancer
  • Non-small Cell Lung Cancer
  • AIDS-related Kaposi's Sarcoma
  • Ovarian Cancer
  • Stomach Cancer
  • Cervical Cancer
  • Esophageal Cancer
  • Testicular Cancer
  • Lung Cancer
  • Pancreatic Cancer
  • Others

GLOBAL PACLITAXEL INJECTION MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Cancer Research Centers
  • Hospital
  • Others

GLOBAL PACLITAXEL INJECTION MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1.Paclitaxel Injection Market Overview

  • 1.1.Study Scope
  • 1.2.Market Estimation Years

2.Executive Summary

  • 2.1.Market Snippet
    • 2.1.1.Paclitaxel Injection Market Snippet by Indication Type
    • 2.1.2.Paclitaxel Injection Market Snippet by Application
    • 2.1.3.Paclitaxel Injection Market Snippet by Country
    • 2.1.4.Paclitaxel Injection Market Snippet by Region
  • 2.2.Competitive Insights

3.Paclitaxel Injection Key Market Trends

  • 3.1.Paclitaxel Injection Market Drivers
    • 3.1.1.Impact Analysis of Market Drivers
  • 3.2.Paclitaxel Injection Market Restraints
    • 3.2.1.Impact Analysis of Market Restraints
  • 3.3.Paclitaxel Injection Market Opportunities
  • 3.4.Paclitaxel Injection Market Future Trends

4.Paclitaxel Injection Industry Study

  • 4.1.PEST Analysis
  • 4.2.Porter's Five Forces Analysis
  • 4.3.Growth Prospect Mapping
  • 4.4.Regulatory Framework Analysis

5.Paclitaxel Injection Market: COVID-19 Impact Analysis

  • 5.1.Pre-COVID-19 Impact Analysis
  • 5.2.Post-COVID-19 Impact Analysis
    • 5.2.1.Top Performing Segments
    • 5.2.2.Marginal Growth Segments
    • 5.2.3.Top Looser Segments
    • 5.2.4.Marginal Loss Segments

6.Paclitaxel Injection Market Landscape

  • 6.1.Paclitaxel Injection Market Share Analysis, 2023
  • 6.2.Breakdown Data, by Key Manufacturer
    • 6.2.1.Established Players' Analysis
    • 6.2.2.Emerging Players' Analysis

7.Paclitaxel Injection Market - By Indication Type

  • 7.1.Overview
    • 7.1.1.Segment Share Analysis, By Indication Type, 2023 & 2032 (%)
    • 7.1.2.Prostate Cancer
    • 7.1.3.Breast Cancer
    • 7.1.4.Non-small Cell Lung Cancer
    • 7.1.5.AIDS-related Kaposi's Sarcoma
    • 7.1.6.Ovarian Cancer
    • 7.1.7.Stomach Cancer
    • 7.1.8.Cervical Cancer
    • 7.1.9.Esophageal Cancer
    • 7.1.10.Testicular Cancer
    • 7.1.11.Lung Cancer
    • 7.1.12.Pancreatic Cancer
    • 7.1.13.Others

8.Paclitaxel Injection Market - By Application

  • 8.1.Overview
    • 8.1.1.Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 8.1.2.Cancer Research Centers
    • 8.1.3.Hospital
    • 8.1.4.Others

9.Paclitaxel Injection Market- By Geography

  • 9.1.Introduction
    • 9.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 9.2.North America
    • 9.2.1.Overview
    • 9.2.2.Paclitaxel Injection Key Manufacturers in North America
    • 9.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.2.4.North America Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
    • 9.2.5.North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.2.6.U.S.
      • 9.2.6.1.Overview
      • 9.2.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.2.6.3.U.S. Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 9.2.6.4.U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.2.7.Canada
      • 9.2.7.1.Overview
      • 9.2.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.2.7.3.Canada Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 9.2.7.4.Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.3.Europe
    • 9.3.1.Overview
    • 9.3.2.Paclitaxel Injection Key Manufacturers in Europe
    • 9.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.3.4.Europe Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
    • 9.3.5.Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.6.Germany
      • 9.3.6.1.Overview
      • 9.3.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.6.3.Germany Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 9.3.6.4.Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.7.Italy
      • 9.3.7.1.Overview
      • 9.3.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.7.3.Italy Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 9.3.7.4.Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.8.United Kingdom
      • 9.3.8.1.Overview
      • 9.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.8.3.United Kingdom Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 9.3.8.4.United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.9.France
      • 9.3.9.1.Overview
      • 9.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.9.3.France Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 9.3.9.4.France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.10.Russia
      • 9.3.10.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.10.2.Russia Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 9.3.10.3.Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.11.Netherlands
      • 9.3.11.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.11.2.Netherlands Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 9.3.11.3.Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.12.Sweden
      • 9.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.12.2.Sweden Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 9.3.12.3.Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.13.Poland
      • 9.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.13.2.Poland Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 9.3.13.3.Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.14.Rest of Europe
      • 9.3.14.1.Overview
      • 9.3.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.14.3.Rest of the Europe Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 9.3.14.4.Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.4.Asia Pacific (APAC)
    • 9.4.1.Overview
    • 9.4.2.Paclitaxel Injection Key Manufacturers in Asia Pacific
    • 9.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.4.4.Asia Pacific Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
    • 9.4.5.Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.6.India
      • 9.4.6.1.Overview
      • 9.4.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.6.3.India Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 9.4.6.4.India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.7.China
      • 9.4.7.1.Overview
      • 9.4.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.7.3.China Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 9.4.7.4.China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.8.Japan
      • 9.4.8.1.Overview
      • 9.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.8.3.Japan Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 9.4.8.4.Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.9.South Korea
      • 9.4.9.1.Overview
      • 9.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.9.3.South Korea Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 9.4.9.4.South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.10.Australia
      • 9.4.10.1.Overview
      • 9.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.10.3.Australia Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 9.4.10.4.Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.11.Thailand
      • 9.4.11.1.Overview
      • 9.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.11.3.Thailand Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 9.4.11.4.Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.12.Indonesia
      • 9.4.12.1.Overview
      • 9.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.12.3.Indonesia Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 9.4.12.4.Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.13.Philippines
      • 9.4.13.1.Overview
      • 9.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.13.3.Philippines Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 9.4.13.4.Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.14.Rest of APAC
      • 9.4.14.1.Overview
      • 9.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.14.3.Rest of APAC Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 9.4.14.4.Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.5.Latin America
    • 9.5.1.Overview
    • 9.5.2.Paclitaxel Injection Key Manufacturers in Latin America
    • 9.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.5.4.Latin America Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
    • 9.5.5.Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.5.6.Brazil
      • 9.5.6.1.Overview
      • 9.5.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.6.3.Brazil Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 9.5.6.4.Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.5.7.Mexico
      • 9.5.7.1.Overview
      • 9.5.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.7.3.Mexico Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 9.5.7.4.Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.5.8.Argentina
      • 9.5.8.1.Overview
      • 9.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.8.3.Argentina Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 9.5.8.4.Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.5.9.Colombia
      • 9.5.9.1.Overview
      • 9.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.9.3.Colombia Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 9.5.9.4.Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.5.10.Rest of LATAM
      • 9.5.10.1.Overview
      • 9.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.10.3.Rest of LATAM Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 9.5.10.4.Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.6.Middle East and Africa
    • 9.6.1.Overview
    • 9.6.2.Paclitaxel Injection Key Manufacturers in Middle East and Africa
    • 9.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.6.4.Middle East and Africa Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
    • 9.6.5.Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.6.Saudi Arabia
      • 9.6.6.1.Overview
      • 9.6.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.6.3.Saudi Arabia Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 9.6.6.4.Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.7.United Arab Emirates
      • 9.6.7.1.Overview
      • 9.6.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.7.3.United Arab Emirates Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 9.6.7.4.United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.8.Israel
      • 9.6.8.1.Overview
      • 9.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.8.3.Israel Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 9.6.8.4.Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.9.Turkey
      • 9.6.9.1.Overview
      • 9.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.9.3.Turkey Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 9.6.9.4.Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.10.Algeria
      • 9.6.10.1.Overview
      • 9.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.10.3.Algeria Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 9.6.10.4.Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.11.Egypt
      • 9.6.11.1.Overview
      • 9.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.11.3.Egypt Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 9.6.11.4.Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.12.Rest of MEA
      • 9.6.12.1.Overview
      • 9.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.12.3.Rest of MEA Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 9.6.12.4.Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)

10.Key Vendor Analysis- Paclitaxel Injection Industry

  • 10.1.Competitive Dashboard
  • 10.2.Company Profiles
    • 10.2.1.Pfizer
    • 10.2.2.Celgene Corporation
    • 10.2.3.Fresenius Kabi Oncology Ltd
    • 10.2.4.Abbott Laboratories
    • 10.2.5.Onco Therapies Ltd (Strides Arcolab Ltd.)
    • 10.2.6.Sagent Pharmaceuticals
    • 10.2.7.Bristol Myers Squibb
    • 10.2.8.Luye Pharma Group
    • 10.2.9.NOVASEP
    • 10.2.10.Others

11.360 Degree Analyst View

12.Appendix

  • 12.1.Research Methodology
  • 12.2.References
  • 12.3.Abbreviations
  • 12.4.Disclaimer
  • 12.5.Contact Us